scispace - formally typeset
V

Vivian Barak

Researcher at Hebrew University of Jerusalem

Publications -  150
Citations -  6186

Vivian Barak is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Cytokine & Tumor necrosis factor alpha. The author has an hindex of 39, co-authored 148 publications receiving 5849 citations. Previous affiliations of Vivian Barak include Hadassah Medical Center.

Papers
More filters
Journal ArticleDOI

Clinical utility of cytokeratins as tumor markers.

TL;DR: The clinical value of determining soluble cytokeratins protein fragments in body fluids lies in the early detection of recurrence and the fast assessment of the efficacy of therapy response in epithelial cell carcinomas.
Journal ArticleDOI

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

TL;DR: Recommendations are presented for the routine clinical use of serum and tissue-based markers in the diagnosis and management of patients with breast cancer and recently validated prognostic markers for lymph node-negative breast cancer patients may be of value in selecting node- negative patients that do not require adjuvant chemotherapy.
Journal ArticleDOI

Cerebrospinal cytokine levels in patients with acute depression.

TL;DR: A positive correlation was found between serum IL-1β and the severity of depression and this results indicate a unique profile for CSF proinflammatory cytokines in acute depression.